Literature DB >> 18097850

RF-power and temperature data analysis of 444 patients with primary cervical cancer: deep hyperthermia using the Sigma-60 applicator is reproducible.

Daryoush Fatehi1, Jacoba van der Zee, Maarten de Bruijne, Martine Franckena, Gerard C van Rhoon.   

Abstract

Treatment reproducibility is important to guarantee reproducible treatment-outcome, a low-complication rate and efficient treatment procedures. This study evaluated the performance of loco-regional deep hyperthermia with four BSD-2000 configurations during 1990-2005 using the direct available parameters, i.e., temperature and power. Primary cervical cancer patients (n = 444) were all treated within the Sigma-60. Patients were grouped in three weight-groups: <61 kg, 61-70 kg, >70 kg. Different temperature and power indices were extensively analyzed per BSD configuration, per weight-group, and over the time-period. No substantial variations were found for temperature/power indices over the four BSD configurations or for the temperature doses in similar weight-groups. The 'bare' power indices were increased with weight; however, the derivative power-related (W/kg, W/cm(2)) and temperature indices decreased. Large variations were found in the power-related parameters during 1991-1996 (1st time-period), whereas they were much smaller during 1997-2005 (2nd time-period). The most relevant change noted was the adaptation of the treatment strategy with respect to power modulation. The average frequency of switched-off was 3.4 and 8.9 times/treatment session for the 1st and 2nd time-period, respectively, while the average duration of each switched-off time was 78.2 vs. 38.3 s. The yearly average of vagina T(50) was in the range of 39.3-40.2 degrees C (1st time-period) and 40.0-40.5 degrees C (2nd time-period). In 40% of the patients, a positive correlation was found between normalized net integrated power per pelvic area and vagina T(50). Good reproducible heating is achieved with the BSD-2000 Sigma-60 irrespective of the regular technological upgrades of the system and variation of trained staff-members.

Entities:  

Mesh:

Year:  2007        PMID: 18097850     DOI: 10.1080/02656730701827557

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  4 in total

1.  Mild hyperthermia with magnetic resonance-guided high-intensity focused ultrasound for applications in drug delivery.

Authors:  Ari Partanen; Pavel S Yarmolenko; Antti Viitala; Sunil Appanaboyina; Dieter Haemmerich; Ashish Ranjan; Genevieve Jacobs; David Woods; Julia Enholm; Bradford J Wood; Matthew R Dreher
Journal:  Int J Hyperthermia       Date:  2012       Impact factor: 3.914

2.  Endocervical ultrasound applicator for integrated hyperthermia and HDR brachytherapy in the treatment of locally advanced cervical carcinoma.

Authors:  Jeffery H Wootton; I-Chow Joe Hsu; Chris J Diederich
Journal:  Med Phys       Date:  2011-02       Impact factor: 4.071

Review 3.  Magnetic Resonance-Guided Drug Delivery.

Authors:  Andrew S Mikhail; Ari Partanen; Pavel Yarmolenko; Aradhana M Venkatesan; Bradford J Wood
Journal:  Magn Reson Imaging Clin N Am       Date:  2015-07-09       Impact factor: 2.266

Review 4.  Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma.

Authors:  Ludy Lutgens; Jacoba van der Zee; Madelon Pijls-Johannesma; Danielle Fm De Haas-Kock; Jeroen Buijsen; Ghislaine Apg van Mastrigt; Guido Lammering; Dirk K M De Ruysscher; Philippe Lambin
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.